These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3734238)

  • 1. Trends in the presentation and treatment of basal cell carcinomas.
    Roenigk RK; Ratz JL; Bailin PL; Wheeland RG
    J Dermatol Surg Oncol; 1986 Aug; 12(8):860-5. PubMed ID: 3734238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial.
    Smeets NW; Krekels GA; Ostertag JU; Essers BA; Dirksen CD; Nieman FH; Neumann HA
    Lancet; 2004 Nov 13-19; 364(9447):1766-72. PubMed ID: 15541449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma.
    Paoli J; Daryoni S; Wennberg AM; Mölne L; Gillstedt M; Miocic M; Stenquist B
    Acta Derm Venereol; 2011 Oct; 91(6):689-93. PubMed ID: 21681360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mohs micrographic surgery for repeat excision of basal cell carcinomas on the head with positive margins].
    Angulo J; Serra-Guillén C; Traves V; Botella-Estrada R; Sanmartín O; Llombart B; Requena C; Guillén C; Nagore E
    Actas Dermosifiliogr; 2011 Dec; 102(10):797-804. PubMed ID: 21684507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large, aggressive basal-cell carcinomas of the scalp.
    Binstock JH; Stegman SJ; Tromovitch TA
    J Dermatol Surg Oncol; 1981 Jul; 7(7):565-9. PubMed ID: 7251965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mohs' method of micrographic surgery as treatment for recurrent basal cell carcinoma].
    van Baardwijk AA; Verhaegh ME; Krekels GA; Vermeulen AH; Neumann HA
    Ned Tijdschr Geneeskd; 1997 Mar; 141(11):524-9. PubMed ID: 9190509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Why is it important to differentiate trichoblastic carcinomas (CT) from basal cell carcinomas (CBC). About 21 cases].
    Thomas M; Bruant-Rodier C; Bodin F; Cribier B; Huther M; Dissaux C
    Ann Chir Plast Esthet; 2017 Jun; 62(3):212-218. PubMed ID: 28385570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapses and recurrences of basal cell face carcinomas.
    Ocanha JP; Dias JT; Miot HA; Stolf HO; Marques ME; Abbade LP
    An Bras Dermatol; 2011; 86(2):386-8. PubMed ID: 21603832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
    Lawrence CM; Haniffa M; Dahl MG
    Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
    Cohen PR; Schulze KE; Nelson BR
    Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excision].
    Spraul CW; Ahr WM; Lang GK
    Klin Monbl Augenheilkd; 2000 Oct; 217(4):207-14. PubMed ID: 11098454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
    Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
    Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.
    Silverman MK; Kopf AW; Grin CM; Bart RS; Levenstein MJ
    J Dermatol Surg Oncol; 1991 Sep; 17(9):720-6. PubMed ID: 1820764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.
    Fantini BC; Bueno Filho R; Chahud F; Souza CDS
    J Dermatolog Treat; 2019 Feb; 30(1):74-80. PubMed ID: 29727201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosurgical reports: perineural spread of basal-cell carcinoma.
    Hanke CW; Wolf RL; Hochman SA; O'Brian JJ
    J Dermatol Surg Oncol; 1983 Sep; 9(9):742-7. PubMed ID: 6886188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of Mohs' micrographic surgery in two English centres.
    Julian CG; Bowers PW
    Br J Dermatol; 1997 Apr; 136(4):515-8. PubMed ID: 9155950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical margin marking for high-risk basal cell carcinomas of the cephalic region: a single-centre experience.
    Cecchi R; Bartoli L; Brunetti L; Pavesi M; Rapicano V
    G Ital Dermatol Venereol; 2011 Apr; 146(2):79-84. PubMed ID: 21505392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mohs' micrographic surgery of the head and neck.
    Darmstadt GL; Steinman HK
    West J Med; 1990 Feb; 152(2):153-8. PubMed ID: 2407031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mohs micrographic surgery.
    Thomas RM; Amonette RA
    Am Fam Physician; 1988 Mar; 37(3):135-42. PubMed ID: 3348115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.